当前位置:首页 - 行情中心 - 永安药业(002365) - 财务分析 - 现金流量表

永安药业

(002365)

  

流通市值:33.97亿  总市值:40.75亿
流通股本:2.46亿   总股本:2.95亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金483,806,723.73196,635,490.26832,727,212.11604,670,318.15
  收到的税费返还16,639,628.948,067,644.8123,469,372.9218,198,428.7
  收到其他与经营活动有关的现金7,452,147.01884,219.6514,435,234.2424,002,348.12
  经营活动现金流入小计507,898,499.68205,587,354.72870,631,819.27646,871,094.97
  购买商品、接受劳务支付的现金364,014,363.83148,034,050.03534,171,092.27377,848,425.62
  支付给职工以及为职工支付的现金70,031,298.5140,166,984.63119,341,802.8692,699,788.58
  支付的各项税费18,403,911.826,113,412.9923,539,264.0618,644,318.12
  支付其他与经营活动有关的现金23,358,430.6212,704,683.3454,496,241.1459,013,673.77
  经营活动现金流出小计475,808,004.78207,019,130.99731,548,400.33548,206,206.09
  经营活动产生的现金流量净额32,090,494.9-1,431,776.27139,083,418.9498,664,888.88
二、投资活动产生的现金流量:
  收回投资收到的现金507,271,232.56253,891,659.541,057,033,842.43758,986,464.57
  取得投资收益收到的现金8,086,203.914,405,420.5328,009,702.2420,299,520.83
  处置固定资产、无形资产和其他长期资产收回的现金净额368,290-364,095.88,667
  投资活动现金流入小计515,725,726.47258,297,080.071,085,407,640.47779,294,652.4
  购建固定资产、无形资产和其他长期资产支付的现金88,019,094.4541,433,774.6562,277,086.9344,045,461.53
  投资支付的现金456,899,305.84191,296,918.191,143,180,134.33845,330,607.59
  投资活动现金流出小计544,918,400.29232,730,692.841,205,457,221.26889,376,069.12
  投资活动产生的现金流量净额-29,192,673.8225,566,387.23-120,049,580.79-110,081,416.72
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,500,000-
  取得借款收到的现金--15,000,00015,000,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--17,500,00015,000,000
  偿还债务支付的现金--54,500,00026,150,000
  分配股利、利润或偿付利息支付的现金28,818,288.63-29,882,099.3229,661,234.34
  支付其他与筹资活动有关的现金--43,292,817.5435,192,817.54
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计28,818,288.63-127,674,916.8691,004,051.88
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-28,818,288.63--110,174,916.86-76,004,051.88
四、汇率变动对现金及现金等价物的影响-3,209,054.82-1,506,585.831,321,512.161,850,474.49
五、现金及现金等价物净增加额-29,129,522.3722,628,025.13-89,819,566.55-85,570,105.23
  加:期初现金及现金等价物余额230,585,726.41230,585,726.41320,405,292.96320,405,292.96
  期末现金及现金等价物余额201,456,204.04253,213,751.54230,585,726.41234,835,187.73
补充资料:
  净利润42,784,942.19-7,190,064.51-
  资产减值准备3,242.04-16,527,392.86-
  固定资产和投资性房地产折旧54,684,383.33-113,332,466.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧54,684,383.33-113,332,466.25-
  无形资产摊销1,723,955.16-3,504,499.84-
  处置固定资产、无形资产和其他长期资产的损失-8,229.04--185,682.47-
  固定资产报废损失1,015,312.76-185,454.28-
  公允价值变动损失3,416,124.22-1,085,650.93-
  财务费用6,226,072.41-941,505.85-
  投资损失-9,315,453.45--30,560,208.94-
  递延所得税3,434,893.22--10,816,976.04-
  其中:递延所得税资产减少7,728,709.08--5,570,985.66-
    递延所得税负债增加-4,293,815.86--5,245,990.38-
  存货的减少-10,009,890.65-3,631,426.79-
  经营性应收项目的减少-93,531,606.79-39,577,796.94-
  经营性应付项目的增加24,621,833.51--5,205,748.18-
  其他-11,392.76---
  现金的期末余额201,456,204.04-230,585,726.41-
  减:现金的期初余额230,585,726.41-320,405,292.96-
  现金及现金等价物的净增加额-29,129,522.37--89,819,566.55-
公告日期2026-08-282026-04-302026-04-172025-10-30
审计意见(境内)标准无保留意见
TOP↑